• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法治疗息肉样脉络膜血管病变后激光照射区外脉络膜厚度。

Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy.

机构信息

Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan.

出版信息

Jpn J Ophthalmol. 2013 May;57(3):294-300. doi: 10.1007/s10384-013-0230-3. Epub 2013 Feb 14.

DOI:10.1007/s10384-013-0230-3
PMID:23408087
Abstract

PURPOSE

To evaluate changes in choroidal thickness adjacent to the area of laser application after photodynamic therapy (PDT) in patients with polypoidal choroidal vasculopathy (PCV) using enhanced depth imaging spectral-domain optical coherence tomography.

METHODS

Masked observers measured the choroidal thickness at the subfovea and superior, inferior and temporal areas adjacent to the area of laser application before, 2 days, 1 week and 1 and 3 months after treatment.

RESULTS

Thirty-seven patients with PCV treated with PDT with verteporfin were included. The mean subfoveal choroidal thickness decreased significantly (P < 0.001) from 256 ± 115 μm at baseline to 207 ± 111 μm at 3 months; the mean outside choroidal thickness including the superior, inferior and temporal areas decreased significantly (P < 0.001) from 240 ± 92 μm at baseline to 209 ± 86 μm at 3 months.

CONCLUSION

PDT affected not only the subfoveal choroid, but also the choroid outside the area of laser application in PCV.

摘要

目的

应用增强深度成像光谱域光学相干断层扫描(EDI-OCT)评估息肉样脉络膜血管病变(PCV)患者光动力疗法(PDT)后激光治疗区域周围脉络膜厚度的变化。

方法

观察者对 37 例接受维替泊芬 PDT 治疗的 PCV 患者进行了研究,在治疗前、治疗后 2 天、1 周和 1、3 个月,分别对黄斑中心凹下、上方、下方和颞侧毗邻激光治疗区域的脉络膜厚度进行了测量。

结果

256±115μm(基线)至 207±111μm(3 个月),黄斑中心凹下脉络膜厚度显著降低(P<0.001);240±92μm(基线)至 209±86μm(3 个月),包括上方、下方和颞侧的周边脉络膜厚度显著降低(P<0.001)。

结论

PDT 不仅影响黄斑中心凹下脉络膜,还影响 PCV 中激光治疗区域以外的脉络膜。

相似文献

1
Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy.光动力疗法治疗息肉样脉络膜血管病变后激光照射区外脉络膜厚度。
Jpn J Ophthalmol. 2013 May;57(3):294-300. doi: 10.1007/s10384-013-0230-3. Epub 2013 Feb 14.
2
Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.特立氟胺联合吗替麦考酚酯治疗多发性硬化的疗效及安全性:一项前瞻性随机对照研究
Am J Ophthalmol. 2011 Apr;151(4):594-603.e1. doi: 10.1016/j.ajo.2010.10.030. Epub 2011 Feb 4.
3
One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.玻璃体内注射阿柏西普与维替泊芬光动力疗法联合治疗息肉状脉络膜血管病变的一年疗效
Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):541-548. doi: 10.1007/s00417-016-3500-1. Epub 2016 Sep 30.
4
Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.抗血管内皮生长因子药物联合光动力疗法治疗息肉状脉络膜血管病变的长期疗效和安全性。
Indian J Ophthalmol. 2018 Aug;66(8):1119-1127. doi: 10.4103/ijo.IJO_1222_17.
5
Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.维替泊芬光动力疗法治疗渗出性特发性息肉状脉络膜血管病变
Eur J Ophthalmol. 2006 Sep-Oct;16(5):695-704. doi: 10.1177/112067210601600506.
6
Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.息肉样脉络膜血管病变与维替泊芬光动力疗法
Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):973-9. doi: 10.1007/s00417-005-1139-4. Epub 2005 Oct 20.
7
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.在1+PRN方案下光动力疗法、玻璃体内注射雷珠单抗及联合治疗息肉状脉络膜血管病变的疗效比较
BMC Ophthalmol. 2018 Jun 20;18(1):144. doi: 10.1186/s12886-018-0801-7.
8
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.雷珠单抗联合或不联合维替泊芬光动力疗法治疗息肉样脉络膜血管病变的疗效与安全性:一项随机临床试验
JAMA Ophthalmol. 2017 Nov 1;135(11):1206-1213. doi: 10.1001/jamaophthalmol.2017.4030.
9
Role of photodynamic therapy in polypoidal choroidal vasculopathy.光动力疗法在息肉样脉络膜血管病变中的作用。
Jpn J Ophthalmol. 2007 Jul-Aug;51(4):270-7. doi: 10.1007/s10384-007-0452-3. Epub 2007 Aug 3.
10
Intravitreal ranibizumab combined with verteporfin photodynamic therapy for treating polypoidal choroidal vasculopathy.眼内雷珠单抗联合维替泊芬光动力疗法治疗息肉状脉络膜血管病变。
Retina. 2011 Jul-Aug;31(7):1287-93. doi: 10.1097/IAE.0b013e3182003ccd.

引用本文的文献

1
Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy.光动力疗法治疗中心性浆液性脉络膜视网膜病变后脉络膜厚度明显变薄。
Sci Rep. 2023 Jul 5;13(1):10890. doi: 10.1038/s41598-023-37802-w.
2
Morphometrics in three dimensional choroidal vessel models constructed from swept-source optical coherence tomography images.基于扫频源光学相干断层扫描图像构建的脉络膜血管三维形态计量学。
Sci Rep. 2022 Sep 6;12(1):15130. doi: 10.1038/s41598-022-17039-9.
3
Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.

本文引用的文献

1
Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.年龄相关性黄斑变性和息肉状脉络膜血管病变中的脉络膜厚度、血管通透性和补体因子 H。
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3663-72. doi: 10.1167/iovs.12-9619.
2
One-year results of three monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients.日本患者息肉状脉络膜血管病变接受每月三次雷珠单抗注射和按需再注射的一年结果。
Am J Ophthalmol. 2012 Jul;154(1):117-124.e1. doi: 10.1016/j.ajo.2011.12.019. Epub 2012 Apr 1.
3
厚脉络膜疾病与年龄相关性黄斑变性的特征:多模态成像与遗传背景
J Clin Med. 2020 Jun 29;9(7):2034. doi: 10.3390/jcm9072034.
4
Hybrid Three-Dimensional Visualization of Choroidal Vasculature Imaged by Swept-Source Optical Coherence Tomography.扫频光学相干断层扫描成像的脉络膜血管系统的混合三维可视化
Transl Vis Sci Technol. 2019 Oct 22;8(5):31. doi: 10.1167/tvst.8.5.31. eCollection 2019 Sep.
5
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变光动力治疗后视网膜外层微观结构的变化
Clin Ophthalmol. 2017 Aug 16;11:1505-1512. doi: 10.2147/OPTH.S139288. eCollection 2017.
Enhanced depth imaging spectral-domain optical coherence tomography of subfoveal choroidal thickness in normal Japanese eyes.
正常日本人眼黄斑中心凹下脉络膜厚度的增强深度成像谱域光学相干断层扫描。
Jpn J Ophthalmol. 2012 May;56(3):230-5. doi: 10.1007/s10384-012-0128-5. Epub 2012 Mar 23.
4
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变患者对侧眼的中心凹下脉络膜厚度。
Retina. 2011 Sep;31(8):1603-8. doi: 10.1097/IAE.0b013e31820f4b39.
5
Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.光动力疗法治疗息肉状脉络膜血管病变的 3 年随访结果。
Jpn J Ophthalmol. 2011 Jan;55(1):39-44. doi: 10.1007/s10384-010-0886-x. Epub 2011 Feb 18.
6
Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.特立氟胺联合吗替麦考酚酯治疗多发性硬化的疗效及安全性:一项前瞻性随机对照研究
Am J Ophthalmol. 2011 Apr;151(4):594-603.e1. doi: 10.1016/j.ajo.2010.10.030. Epub 2011 Feb 4.
7
Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy.典型年龄相关性黄斑变性和息肉样脉络膜血管病变的中心凹下脉络膜厚度。
Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1123-8. doi: 10.1007/s00417-011-1620-1. Epub 2011 Jan 28.
8
Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration.脉络膜厚度在息肉样脉络膜血管病变和渗出性年龄相关性黄斑变性中的研究。
Ophthalmology. 2011 May;118(5):840-5. doi: 10.1016/j.ophtha.2010.09.012. Epub 2011 Jan 6.
9
Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapy.玻璃体内注射贝伐单抗和经Tenon 囊曲安奈德注射联合防治光动力疗法诱导脉络膜毛细血管闭塞的保护作用。
Ophthalmologica. 2010;224(5):267-73. doi: 10.1159/000287348. Epub 2010 Feb 25.
10
Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.康柏西普眼用注射液治疗息肉状脉络膜血管病变:6 个月结果。
Br J Ophthalmol. 2010 Mar;94(3):297-301. doi: 10.1136/bjo.2008.150029. Epub 2009 Sep 1.